EXTEND BIOSCIENCES INC
- NEWTON, MA 02458-1119
- extendbio.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
- Women-Owned Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
EXTEND BIOSCIENCES INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About EXTEND BIOSCIENCES INC
- Headquarters
- NEWTON, MA 02458-1119
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIDZTKWESJQQ99
- CAGE62TW2
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 15 awards
- Total awarded
- $15,625,347
- By phase
- SBIR Phase I: 9
- SBIR Phase II: 6
- By agency
- Department of Health and Human Services: 10
- Department of Defense: 3
- National Science Foundation: 2
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2024: 1
- 2020: 2
- 2019: 1
- 2017: 4
- 2015: 2
- 2014: 1
- 2013: 4
Awards (most recent first)
Long-acting PTH for hypoparathyroidism
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $1,999,230
Sep 1, 2024 – Aug 31, 2026
Solicitation PA22-177 (2022) · Topic 200
Long-acting PTH for hypoparathyroidism
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $3,000,000
Sep 15, 2020 – May 31, 2022
Solicitation PA19-273 (2019) · Topic 200
Long Duration, Novel Opioid Medical Countermeasure for Intramuscular Injection
SBIR Phase I · Department of Defense (Office for Chemical and Biological Defense) · 2020 · $161,589
Mar 12, 2020 – Sep 13, 2020
Solicitation 19.2 (2019) · Topic CBD192-008
Long-acting ghrelin for neuropathy
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $535,325
Sep 30, 2019 – Aug 31, 2020
Solicitation PA18-574 (2018) · Topic 103
Long-acting PTH for hypoparathyroidism
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $3,730,799
Sep 15, 2017 – Jul 31, 2019
Solicitation PA16-302 (2016) · Topic NIDDK
Ultralong acting insulin for diabetes
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $350,000
Sep 6, 2017 – Sep 5, 2019
Solicitation PA16-302 (2016) · Topic 200
Long-acting ghrelin for the treatment of cancer cachexia
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $2,212,084
Apr 24, 2017 – Mar 31, 2020
- Direct to Phase II
Solicitation PA18-591 (2016) · Topic 102
Long-acting ghrelin for the treatment of ARS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $600,000
Mar 1, 2017 – Feb 28, 2019
Solicitation PA15-065 (2015) · Topic R
Long acting PTH for hypoparathyroidism
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $306,738
Sep 24, 2015 – Aug 31, 2016
Solicitation PA14-071 (2015) · Topic 200
SBIR Phase II: A platform technology that significantly improves drug delivery
SBIR Phase II · National Science Foundation · 2015 · $741,634
Nov 10, 2014 – Oct 31, 2016
Solicitation year 2014 · Topic BC
Enhancing the Pharmacokinetic Profile of Protein-based Drugs
SBIR Phase II · Department of Defense (Office for Chemical and Biological Defense) · 2014 · $999,998
May 21, 2015 – Jun 25, 2016
Solicitation 2012.2 (2012) · Topic CBD12-101
Enhancing the Pharmacokinetic Profile of Protein-based Drugs
SBIR Phase I · Department of Defense (Office for Chemical and Biological Defense) · 2013 · $99,999
Mar 25, 2013 – Sep 25, 2013
Solicitation 2012.2 (2012) · Topic CBD12-101 · Research partner: Stub
SBIR Phase I: Carriers for Improved Drug Delivery of Biopharmaceuticals
SBIR Phase I · National Science Foundation · 2013 · $150,000
Jan 1, 2013 – Dec 31, 2013
Solicitation year 2012 · Topic BC
Monitor for Multiple Biomarkers for Detection of Alcohol Consumption
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $449,649
Solicitation PA12-088 (2013) · Topic NIAAA · Research partner: Stub
Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $288,302
Solicitation PA12-088 (2013) · Topic NCI · Research partner: Stub
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Socio-economic status
Self-represented in SAM.gov. WOSB and EDWOSB set-asides need SBA certification (13 CFR 127.300); SDVOSB and VOSB need SBA VetCert (13 CFR part 128). Confirm current certification before relying on it.
Learn more about small business set-asidesProduct & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with EXTEND BIOSCIENCES INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
